Europe patent authority rules for PDL antibody technology patent

04/24/2007 | Forbes

The European Patent Office ruled PDL Biopharma's patent for its daclizumab antibody technology currently in trials is protected from competition. Though 18 companies originally had challenged the patent, Genentech and four others withdrew their opposition before the decision was made.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel, Regulatory
Cardinal Health
Waukegan, IL
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Sr Manager, Business Conduct
Gilead Sciences
Foster City, CA
Chief Executive Officer
UCare Minnesota
Minneapolis, MN